Journal
Article title
Title variants
Languages of publication
Abstracts
We describe here tha current state of progress toward gene-directed antisense-based cancer therapy targeting BCR/ABL, oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animal models of human leukemias and phase I clinical investigations.
Discipline
Journal
Year
Issue
Pages
108-115
Physical description
Contributors
References
Document Type
article
Publication order reference
T.Skorski, Kimmel Cancer Center, Thomas Jefferson University, BLSB630, 233 South 10th Street, Philadephia, PA 19107, USA
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-1cfc1613-86da-3918-a586-428516de46a5